- Organizations: Bausch + Lomb
Products
Bausch + Lomb launches Blink Triple Care PF eye drops
Preservative-free lubricant features hyaluronic acid and castor oil to offer a 3-in-1 extended dry eye symptom relief for up to 10 hours.
Research
PreserVision AREDS3 launch highlights B vitamins’ potential role in AMD
Bausch + Lomb advanced PreserVision formula spotlights the unique B-vitamin complex in reducing the risk for AMD, especially in earlier stages.
Events
B+L Vision Care Summit spotlights contact lens and technology advancements
Clinicians share insights on dry eye care, contact lens adoption, and patient-centered treatment approaches.
Events
Nutritional supplementation is redefining eye health management
Highlights from Bausch + Lomb’s first-ever consumer summit.
Events
B+L Consumer Summit highlights OTC integration as key to managing ocular surface health
Clinicians emphasize over-the-counter options as a first-line treatment for ocular surface disease during Bausch + Lomb’s one-day consumer summit.
Products
FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology
Dual-port vitrectomy cutter increases cutting speed from 15K to 25K per minute, while Adaptive Fluidics update expands capabilities of the Stellaris Elite system
Pipeline
Positive 24-month data supports the Elios System for glaucoma treatment
Microinvasive, implant-free procedure used excimer laser technology to lower IOP by 20% or greater among 76% of glaucoma and cataract patients
Research
Study: enVista Aspire IOL delivers expanded intermediate vision without sacrificing distance
Prospective study evaluates the enhanced monofocal IOL among patients undergoing standard phaco.
Business
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants
Collaboration involves the Epidel prodrug platform, which engineers polymer-free drugs with customized, repeat doses and durations for ophthalmic diseases.
Research
Pivotal study showcases enVista Envy IOL's full range of vision
Data includes meeting all efficacy and safety outcomes, with the lens demonstrating statistical superiority in visual outcomes and a favorable dysphotopsia profile.
Research
New data reinforces XIIDRA's eye dryness relief among CL wearers
Open-label study evaluated effectiveness of lifitegrast 5%, noting significant improvements in end-of-day dryness and discomfort in just 2 weeks.
Products
Bausch + Lomb launches ASANA gas permeable lenses
Latest addition to the company’s GP lens portfolio is a versatile lens custom designed to provide advanced visual acuity and all-day shape maintenance.
Research
New phase 3 data compares efficacy of Lumify PF to Lumify drops for ocular redness reduction
Randomized trial reports favorable outcomes in evaluating the safety and efficacy of the preservative-free brimonidine tartrate (0.025%) formulation.
Business
Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes
Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.
Research
Bausch + Lomb unveils 2025 state of dry eye survey results
Building on 2024 findings, latest results indicate a need for more patient education to dispel ongoing misconceptions surrounding dry eye.
Products
Bausch + Lomb launches two new eye drops to Blink portfolio
Now available at most U.S. retailers, the latest additions to this specialty product line includes Blink Nourish Lubricating and Blink Boost Lubricating eye drops.Products
Bausch + Lomb launches PF LUMIFY redness reliever drops
Newest preservative-free, OTC formulation of low-dose brimonidine tartrate is available in single-use vials to relieve eye redness due to minor ocular irritations.
Products
B+L launches Zenlens CHROMA HOA scleral contact lenses
Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
Products
B+L's enVista IOLs return to market after voluntary recall
Company announces conclusion of investigation into reported cases of TASS involving the enVista IOL product line.
Products